Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
B
Brett Daughdrill
Researcher
Also affiliated: University of Arkansas Medical Center (2025)
Unknown Researcher
6 pubs
Research Areas
Biography and Research Information
OverviewAI-generated summary
Brett Daughdrill's research investigates cardiovascular health outcomes, particularly in relation to advanced cancer therapies and specific patient populations. His work includes the prediction of major adverse cardiac events in recipients of CAR-T cell therapy, utilizing risk score modeling and focusing on the role of cytokine release syndrome in guiding cardiotoxicity surveillance. Daughdrill has also examined predictors of adverse cardiovascular events following CAR-T therapy and explored echocardiographic indices for prognostication of heart failure outcomes in individuals with sickle cell disease. His publications address disparities in healthcare access, such as state Medicaid limitations for cardiac rehabilitation programs and their impact on disadvantaged communities. Daughdrill collaborates with researchers including J. Curran Henson, Grant M. Spears, and Adetayo Odueke from the University of Arkansas for Medical Sciences and the University of Arkansas at Fayetteville.
Metrics
- Publications: 6
Selected Publications
-
Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell Therapy: Clinical Characteristics and Impact on Mortality (2026)
-
Bridging the Coverage Gap: State Medicaid Limitations for Cardiac Rehabilitation Programs and the Risk to Disadvantaged Communities (2026)
-
26-A-9693-ACC PREDICTION OF 1-YEAR MAJOR ADVERSE CARDIAC EVENTS IN CAR-T RECIPIENTS USING RISK SCORE MODELING: EXPANDED WHOLE-COHORT ANALYSIS (2026)
-
26-A-11133-ACC CYTOKINE RELEASE SYNDROME-GUIDED RISK MODELS REDEFINE CARDIOTOXICITY SURVEILLANCE: OPTIMIZING DETECTION OF CANCER THERAPY-RELATED CARDIAC DYSFUNCTION AND ADVERSE CARDIOVASCULAR EVENTS AFTER CAR-T THERAPY (2026)
-
PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY (2025)
-
ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE (2025)
Collaboration Network
Top Collaborators
J. Curran Henson
University of Arkansas for Medical Sciences
5 shared publications
In database
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- 26-A-11133-ACC CYTOKINE RELEASE SYNDROME-GUIDED RISK MODELS REDEFINE CARDIOTOXICITY SURVEILLANCE: OPTIMIZING DETECTION OF CANCER THERAPY-RELATED CARDIAC DYSFUNCTION AND ADVERSE CARDIOVASCULAR EVENTS AFTER CAR-T THERAPY
- 26-A-9693-ACC PREDICTION OF 1-YEAR MAJOR ADVERSE CARDIAC EVENTS IN CAR-T RECIPIENTS USING RISK SCORE MODELING: EXPANDED WHOLE-COHORT ANALYSIS
- Bridging the Coverage Gap: State Medicaid Limitations for Cardiac Rehabilitation Programs and the Risk to Disadvantaged Communities
Sruthi Vellanki
University of Arkansas for Medical Sciences
3 shared publications
In database
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- 26-A-11133-ACC CYTOKINE RELEASE SYNDROME-GUIDED RISK MODELS REDEFINE CARDIOTOXICITY SURVEILLANCE: OPTIMIZING DETECTION OF CANCER THERAPY-RELATED CARDIAC DYSFUNCTION AND ADVERSE CARDIOVASCULAR EVENTS AFTER CAR-T THERAPY
- 26-A-9693-ACC PREDICTION OF 1-YEAR MAJOR ADVERSE CARDIAC EVENTS IN CAR-T RECIPIENTS USING RISK SCORE MODELING: EXPANDED WHOLE-COHORT ANALYSIS
Anup Kumar Trikannad
University of Arkansas for Medical Sciences
3 shared publications
In database
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
- 26-A-11133-ACC CYTOKINE RELEASE SYNDROME-GUIDED RISK MODELS REDEFINE CARDIOTOXICITY SURVEILLANCE: OPTIMIZING DETECTION OF CANCER THERAPY-RELATED CARDIAC DYSFUNCTION AND ADVERSE CARDIOVASCULAR EVENTS AFTER CAR-T THERAPY
- 26-A-9693-ACC PREDICTION OF 1-YEAR MAJOR ADVERSE CARDIAC EVENTS IN CAR-T RECIPIENTS USING RISK SCORE MODELING: EXPANDED WHOLE-COHORT ANALYSIS
Srikanth Vallurupalli
University of Arkansas for Medical Sciences
2 shared publications
In database
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
Cesar Gentille Sanchez
University of Arkansas for Medical Sciences
2 shared publications
In database
- 26-A-11133-ACC CYTOKINE RELEASE SYNDROME-GUIDED RISK MODELS REDEFINE CARDIOTOXICITY SURVEILLANCE: OPTIMIZING DETECTION OF CANCER THERAPY-RELATED CARDIAC DYSFUNCTION AND ADVERSE CARDIOVASCULAR EVENTS AFTER CAR-T THERAPY
- 26-A-9693-ACC PREDICTION OF 1-YEAR MAJOR ADVERSE CARDIAC EVENTS IN CAR-T RECIPIENTS USING RISK SCORE MODELING: EXPANDED WHOLE-COHORT ANALYSIS
Robert F. Brand
University of Arkansas for Medical Sciences
1 shared publication
In database
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
Savannah Tidd
University of Arkansas for Medical Sciences
1 shared publication
In database
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
Nitesh Gautam
University of Arkansas for Medical Sciences
1 shared publication
In database
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
Niroshi Wijewardane
University of Arkansas for Medical Sciences
1 shared publication
In database
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
Grant Robinson
University of Arkansas for Medical Sciences
1 shared publication
In database
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
K Sivakumar
University of Arkansas for Medical Sciences
1 shared publication
In database
- ECHOCARDIOGRAPHIC INDICES FOR PROGNOSTICATION OF HEART FAILURE OUTCOMES IN SICKLE CELL DISEASE
Adetayo Odueke
University of Arkansas for Medical Sciences
1 shared publication
In database
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
Carolina Schinke
University of Arkansas for Medical Sciences
1 shared publication
In database
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
Cesar Gentille Sanchez
University of Arkansas for Medical Sciences
1 shared publication
In database
- PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY
Srikanth Vallurupalli
University of Arkansas for Medical Sciences
1 shared publication
In database
- 26-A-11133-ACC CYTOKINE RELEASE SYNDROME-GUIDED RISK MODELS REDEFINE CARDIOTOXICITY SURVEILLANCE: OPTIMIZING DETECTION OF CANCER THERAPY-RELATED CARDIAC DYSFUNCTION AND ADVERSE CARDIOVASCULAR EVENTS AFTER CAR-T THERAPY
Similar Researchers
Based on overlapping research topics
Tala Ghatasheh
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Cancer Treatment and Pharmacology
Health disparities and outcomes
Muthu Veeraputhiran
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Cancer Treatment and Pharmacology
Retrospective Studies
Bradley Fugere
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Cancer Treatment and Pharmacology
Health disparities and outcomes
Jaskirat Sethi
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Cancer Treatment and Pharmacology
Health disparities and outcomes
Brittany Flippo
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Health disparities and outcomes
Retrospective Studies
Suzette Lopez
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Health disparities and outcomes
Retrospective Studies